MetaADEDB 2.0 @ LMMD
Hyperviscosity syndrome
(UMLS:C0221030)
UMLS ID:
C0221030
MeSH ID:
N/A
Synonym(s)
1.
Hyperviscosity syndrome
2.
HYPERVISCOSITY SYNDROME
3.
Reimann's syndrome
4.
hyperviscosity syndrome
5.
hyperviscosity syndromes
Associated Drug(s)
NameNumber of ReportsReference(s)Data Source
1LenalidomideFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
2BortezomibFAERS: 7OFFSIDES
SIDER
US FAERS
3Imatinib MesylateFAERS: 7US FAERS
4PCI 32765FAERS: 3US FAERS
5BosentanFAERS: 2OFFSIDES
US FAERS
6pomalidomideFAERS: 2US FAERS
74-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamideFAERS: 1US FAERS
8AzacitidineFAERS: 1US FAERS
9ClozapineFAERS: 1US FAERS
10EverolimusFAERS: 1US FAERS
11HeminFAERS: 1US FAERS
12HydroxyureaFAERS: 1US FAERS
13Imatinib MesylateFAERS: 1US FAERS
14MemantineFAERS: 1US FAERS
15ParoxetineFAERS: 1US FAERS
16Ruxolitinib phosphateFAERS: 1US FAERS
17TeriparatideFAERS: 1US FAERS
18TestosteroneFAERS: 1US FAERS
19ixazomibFAERS: 1US FAERS
20venetoclaxFAERS: 1US FAERS
21BisacodylOFFSIDES
22EtoposideOFFSIDES
23FluconazoleOFFSIDES
24FosinoprilOFFSIDES
25IsradipineOFFSIDES
26KetamineOFFSIDES
27PamidronateOFFSIDES
28ProchlorperazineOFFSIDES
29VorinostatOFFSIDES
30Zoledronic AcidOFFSIDES
31calcium acetateOFFSIDES
32fludarabine phosphateOFFSIDES
33gliquidoneOFFSIDES
34pipamperoneOFFSIDES
35repaglinideOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.